Literature DB >> 14989492

Expression of IGR-IR and VEGF and trophoblastic proliferative activity in placentas from pregnancies complicated by IUGR.

Duygu Gurel1, Erdener Ozer, Sabahattin Altunyurt, Serkan Guclu, Namik Demir.   

Abstract

Intrauterine growth retardation (IUGR) is recognized as an important cause of low birth weight and elective preterm delivery. IUGR is associated with multiple causative factors, including placental dysfunction. The aim of this prospective study was to investigate the role of trophoblastic proliferative activity and type I insuline-like growth factor receptor (IGF-IR) and vascular endothelial growth factor (VEGF) expressions in the pathogenesis of IUGR. Immunohistochemistry using VEGF, IGF-IR, and Ki-67 antibodies was performed on formalin-fixed placental tissues of third-trimester pregnancies complicated by IUGR (n = 19) and pregnancies with appropriately grown fetuses (n = 27). In addition, histopathological examination of the placentas was performed, and histological findings were categorized into three groups: utero-placental vascular pathologies (UPVP), coagulation-related pathologies, and chronic inflammation. Statistical analysis revealed that villous trophoblastic IGF-IR immunostaining was significantly weaker in placentas with IUGR (p < 0.001), whereas trophoblastic Ki-67 proliferative index and VEGF immunoscoring did not show any significant difference. Histologically, UPVP and chronic inflammation were significant findings in placentas with IUGR (p = 0.04 and p = 0.04, respectively). In addition, placentas were significantly smaller in the IUGR group (p < 0.001). We conclude that villous trophoblastic IGF-IR expression may play a significant role in the pathogenesis of IUGR, and histopathological examination of placentas in pregnancies complicated by IUGR may yield significant findings. In contrast, based on our findings, trophoblastic proliferation and VEGF expression are unlikely to be significant parameters in the pathogenesis of IUGR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14989492     DOI: 10.1078/0344-0338-00499

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  Human placental GLUT1 glucose transporter expression and the fetal insulin-like growth factor axis in pregnancies complicated by diabetes.

Authors:  Marcus H Borges; Janet Pullockaran; Patrick M Catalano; Marc U Baumann; Stacy Zamudio; Nicholas P Illsley
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-06-05       Impact factor: 5.187

Review 2.  Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth.

Authors:  Amanda N Sferruzzi-Perri; Ionel Sandovici; Miguel Constancia; Abigail L Fowden
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

Review 3.  Molecular and cellular underpinnings of normal and abnormal human placental blood flows.

Authors:  Yingchun Li; Ramón A Lorca; Emily J Su
Journal:  J Mol Endocrinol       Date:  2017-11-02       Impact factor: 5.098

4.  Intrauterine growth restriction and placental angiogenesis.

Authors:  Figen Barut; Aykut Barut; Banu Dogan Gun; Nilufer Onak Kandemir; Mehmet Ibrahim Harma; Muge Harma; Erol Aktunc; Sukru Oguz Ozdamar
Journal:  Diagn Pathol       Date:  2010-04-22       Impact factor: 2.644

5.  Placental hypoxia during placental malaria.

Authors:  Philippe Boeuf; Aimee Tan; Cleofe Romagosa; Jane Radford; Victor Mwapasa; Malcolm E Molyneux; Steven R Meshnick; Nicholas H Hunt; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

6.  The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development.

Authors:  Mushi Matjila; Robert Millar; Zephne van der Spuy; Arieh Katz
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.